Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico.
Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials.
Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials.
Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials. J Am Coll Cardiol. 2011 Oct 04; 58(15):1569-77.
View in:
PubMed
subject areas
Aged
Drug-Eluting Stents
Everolimus
Female
Heart Diseases
Humans
Immunosuppressive Agents
Male
Middle Aged
Myocardial Infarction
Myocardial Revascularization
Randomized Controlled Trials as Topic
Sirolimus
Thrombosis
Treatment Outcome
authors with profiles
Usman Baber